Forette F - Search Results

1

Donepezil for the treatment of mild to moderate Alzheimer's disease in France: the economic implications.

Fagnani F, Lafuma A, Pechevis M, Rigaud AS, Traykov L, Seux ML, Forette F. Fagnani F, et al. Among authors: forette f. Dement Geriatr Cogn Disord. 2004;17(1-2):5-13. doi: 10.1159/000074079. Epub 2003 Oct 13. Dement Geriatr Cogn Disord. 2004. PMID: 14560059

2

[Relationship between arterial pressure and cognitive functions. Data for the French Network on Alzheimer's disease (REAL.FR)].

Hanon O, Latour F, Seux ML, Lenoir H, Forette F, Rigaud AS. Hanon O, et al. Among authors: forette f. Rev Med Interne. 2003 Oct;24 Suppl 3:292s-300s. doi: 10.1016/s0248-8663(03)80686-0. Rev Med Interne. 2003. PMID: 14710447 French.

3

Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease.

Gallini A, Gardette V, Vellas B, Lapeyre-Mestre M, Andrieu S, Brefel-Courbon C; REAL.FR/DSA group. Gallini A, et al. Drugs Aging. 2013 Jun;30(6):439-45. doi: 10.1007/s40266-013-0070-3. Drugs Aging. 2013. PMID: 23512718 Free PMC article.

4

The apolipoprotein E epsilon4 allele and the response to tacrine therapy in Alzheimer's disease.

Rigaud AS, Traykov L, Caputo L, Guelfi MC, Latour F, Couderc R, Moulin F, de Rotrou J, Forette F, Boller F. Rigaud AS, et al. Among authors: forette f. Eur J Neurol. 2000 May;7(3):255-8. doi: 10.1046/j.1468-1331.2000.00073.x. Eur J Neurol. 2000. PMID: 10886308 Clinical Trial.

5

Effects of hypertension and its treatment on mental function.

Seux ML, Forette F. Seux ML, et al. Among authors: forette f. Curr Hypertens Rep. 1999 Jun;1(3):232-7. doi: 10.1007/s11906-999-0026-5. Curr Hypertens Rep. 1999. PMID: 10981071 Review.

6

Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).

Hanon O, Latour F, Seux ML, Lenoir H, Forette F, Rigaud AS; REAL.FR Group. Hanon O, et al. Among authors: forette f. J Nutr Health Aging. 2005;9(2):106-11. J Nutr Health Aging. 2005. PMID: 15791354

7

Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease.

Traykov L, Rigaud AS, Caputo L, Couderc R, Coste J, Michot JL, de Rotrou J, Amouyel P, Forette F, Boller F. Traykov L, et al. Among authors: forette f. Eur J Neurol. 1999 Jul;6(4):415-21. doi: 10.1046/j.1468-1331.1999.640415.x. Eur J Neurol. 1999. PMID: 10362893 Clinical Trial.

8

Cerebral complications of hypertension.

Rigaud AS, Seux ML, Staessen JA, Birkenhäger WH, Forette F. Rigaud AS, et al. Among authors: forette f. J Hum Hypertens. 2000 Oct-Nov;14(10-11):605-16. doi: 10.1038/sj.jhh.1001118. J Hum Hypertens. 2000. PMID: 11095154 Review.

9

[Cognitive decline and hypertension].

Rigaud AS, Traykov L, Hanon O, Seux ML, Latour F, Lenoir H, Olde-Rikkert M, Forette F. Rigaud AS, et al. Among authors: forette f. Arch Mal Coeur Vaiss. 2003 Jan;96(1):47-51. Arch Mal Coeur Vaiss. 2003. PMID: 12613149 Review. French.

10

Does the benefit of antihypertensive treatment outweigh the risk in very elderly hypertensive patients?

Forette F, Lechowski L, Rigaud AS, Seux ML, Dessi F, Forette B. Forette F, et al. Among authors: forette b. J Hypertens Suppl. 2000 Jul;18(3):S9-12. J Hypertens Suppl. 2000. PMID: 10952082 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page